Navigation Links
Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
Date:6/2/2011

ROCKVILLE, Md., June 2, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO will deliver a corporate presentation on Thursday, June 9, at 8:30 a.m. Eastern Time.

The presentation will take place as part of the Jefferies 2011 Global Healthcare Conference in New York, New York. Dr. Polymeropoulos' remarks will be available live on the Vanda Website, where it also will be archived for 90 days.

To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
2. Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
3. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
4. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
5. Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
6. Vanda Pharmaceuticals Files Shelf Registration Statement
7. Vanda Pharmaceuticals Appoints Chief Financial Officer
8. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
9. Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010
10. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
11. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... obesity and,complications arising from popular aesthetic surgical procedure, ... study,investigating the relationship between complications of body contouring,surgery ... in the occurrence of,such complications with worsening degree ... the July/August 2008 issue of the Aesthetic Surgery,Journal, ...
... MOORESVILLE, N.C., July 30 Anpath Group, Inc.,(OTC ... owned,subsidiary, EnviroSystems, Inc. (ESI) announced that its EnviroTru(R),disinfectant ... Department of,Management Services (DMS) in the State of ... of Green, LLC(TM) ( http://www.aworldofgreen.com ),worked ...
Cached Medicine Technology:Body Contouring Surgery Risk Rises with Increased Body Mass Index 2Body Contouring Surgery Risk Rises with Increased Body Mass Index 3Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 2Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 3
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... “The Best Body Firmers” many people are self-conscious about the ... becomes an option when diet and exercise fail to ... treatments that may appeal to those looking to get the ... the article is an effective mini-overview,” says Dr. Simon Ourian, ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 ... a federal litigation now underway in U.S. District Court, ... Management Order dated May 3rd, the Court has modified ... Pool to eight cases rather than four. The next ... for Thursday, May 23rd. (In re: Actos Product Liability ...
(Date:5/19/2013)... Corpus Christi, TX (PRWEB) May 19, 2013 ... home security systems companies. Homeowners who are considering ... options and services of the nation's leading security system ... security systems reviews the best DIY home security ... results. Every year 6Webs.com reviews dozens of home security ...
(Date:5/19/2013)... 19, 2013 Americans live closer to ... newest American Veterinary Medical Association (AVMA) U.S. Pet Ownership ... owners consider their dog a member of the family, ... as much five years earlier. , According to the ... the national income dedicated to pets has increased every ...
(Date:5/19/2013)... Angeles (PRWEB) May 19, 2013 Yeast infections ... can appear in sensitive areas of the human body. A ... Yeastrol. This new formula provides a unique method of application ... new spray solution is now provided to men and women ... is naturally absorbed in the body through food and is ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
... the combination of just two genes, according to a new study ... of Clinical Endocrinology and Metabolism this week, identifies one gene on ... height in men. These genes may also help explain why men ... of both of these genes you will be taller than a ...
... that, too much sleep and snoring could put you at ... of Buffalo, New York, have found that sleeping more than ... day can damage your health. Experts say this means snoring ... seriously.// ,Dr David Smithard, Consultant in Stroke Medicine ...
... Doctors from England are trialling the first long-acting male contraceptive ... every three months, is a combination of hormones. ,In ... then a pellet of the male hormone testosterone is placed ... from the Royal Kings Hospital in UK says the technique ...
... exercise is a better indicator of heart disease risk than ... risk of heart disease and stroke. Normally, doctors measure blood ... But researchers at University of San Diego now show that ... be treated and detected.// ,They measured the blood pressure ...
... new test really helps detect heart problems. A test for cardiac ... are really having a heart attack. Only 10 to 15 per ... chest pain are actually having a heart attack. Other causes of ... test may take several hours and maybe a formal hospital admission ...
... found that genes contribute to the risk of chronic ... (COPD), the name given to chronic bronchitis and emphysema ... shortness of breath. It's linked with gradual destruction of ... the problem.// ,However, not all smokers go ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: